All In Biotech

Free tool

FAERS Monitor: Nutrilipid 10%

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019531 or its brand name (Nutrilipid 10%, Soybean Oil). Reports on generic versions are filed under their own applications.

Reports

680

Serious

356

52% of reports

Hospitalization

158

Death reported

67

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • chills134
  • pyrexia133
  • nausea83
  • vomiting54
  • chest discomfort45
  • dyspnoea44
  • palpitations34
  • abdominal distension31
  • rash29
  • dizziness28
  • pruritus27
  • abdominal pain23
  • off label use22
  • hyperhidrosis19
  • anaemia17

Reports by year received

View as table
YearReports
20052
20063
20082
20091
20103
20111
20124
20141
20159
201643
201748
201887
2019147
202081
202123
202248
202373
202459
202532
202613

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,479 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chillsSignal13435.430.44,464
chest discomfortSignal4513.610.3515
pyrexiaSignal13311.910.21,338
abdominal distensionSignal319.26.5219
palpitationsSignal349.06.5235
hyperhidrosisSignal194.62.950
vomitingSignal543.62.899
nauseaSignal833.22.7132
abdominal painSignal233.12.030
anaemiaSignal172.81.717
dyspnoeaSignal442.41.836
pruritusSignal272.21.516
rashSignal292.11.415
dizziness281.71.28
off label use220.80.51

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.